Skip to Content

Nunzia Pharmaceutical Corp - Stock Quote NUNZ

Rating as of

Morningstar's Nunzia Pharmaceutical Corp Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - NUNZ

Nunzia Pharmaceutical Corp's Company Profile

Business Description

Nunzia Pharmaceutical Corp is a pharmaceutical and nutraceutical company. The company is involved in the autism treatment industry and the treatment of diseases such as fragile X, ADHD, and PTSD. The firm's products are segregated into adult products, kids' products, and teen products.

1627 West 14th Street
Long Beach, CA, 90813
T +1 714 609-9117
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2021
Stock Type Distressed
Employees 1